PEG2-Induced Pyroptosis Regulates the Expression of HMGB1 and Promotes hEM15A Migration in Endometriosis
article
OA: gold
CC0
⤵ 8 in-corpus citations
Abstract
Endometriosis (EMS) is a common gynecological disease. Prostaglandin E2 (PGE2), which induces chronic pelvic inflammation and cell pyroptosis, a form of programmed cell death based on inflammasome activation, are involved in EMS, but the extent of their involvement and roles remain unclear. The present study aimed to evaluate PGE2-induced pyroptosis in EMS and the influence of PGE2 in EMS progression. Using western blotting, it was found that the expressions of PGE2 and pyroptosis-related proteins (NLRP3, cleaved caspase-1, interleukin (IL)-1β and IL-18) were higher in EMS tissues than in normal endometrial tissues. The levels of PGE2, IL-1β, and IL-18 in the serum of patients with EMS and cell culture fluids were also detected. Using the transwell assay, we verified that PGE2 promoted hEM15A migration via the NLRP3/caspase-1 pyroptotic pathway, and PGE2-induced pyroptosis upregulated the expressions of high mobility group box 1 (HMGB1), E-cadherin, and vimentin. Immunohistochemistry analysis confirmed that PGE2-induced pyroptosis contributed to EMS invasion. These results suggest that PGE2-induced pyroptosis affects the progression of EMS by changing the migration ability of pyroptotic cells and upregulating the expression of HMGB1, E-cadherin, and vimentin. Our findings provide crucial evidence for new treatment pathways and use of anti-inflammatory drugs in EMS.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Endometriosis via openalex
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment via openalex
- Frequent POLE1 p.S297F mutation in Chinese patients with ovarian endometrioid carcinoma via openalex
- Genetics and Inflammation in Endometriosis: Improving Knowledge for Development of New Pharmacological Strategies via openalex
- The link between immunity, autoimmunity and endometriosis: a literature update via openalex
- W2969582423 via openalex
- W2996281828 via openalex
- W3002351308 via openalex
- W3081117584 via openalex
- W3088563509 via openalex
- W3092400718 via openalex
- W3109384477 via openalex
- W3134632803 via openalex
- W3137170773 via openalex
- W3153621446 via openalex
- W3161581033 via openalex
- W3172682710 via openalex
- W3191507597 via openalex
- W3194532738 via openalex
- W4210775218 via openalex
- W4234160457 via openalex
- W1971899784 via openalex
- W6783040096 via openalex
- W2893187680 via openalex
- W2895833591 via openalex
- W2900952118 via openalex
- W2938085684 via openalex
Cited by (8)
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- A dual-targeted liposomal nanosystem for co-delivery of estrogen receptor β antagonist and disulfiram for the non-hormonal treatment of endometriosis 2025
- Hydrogen Sulfide Promotes Functional Endometrium Recovery via Regulating Pyroptosis in Severe Endometrial Injury: A Prospective Laboratory Based Randomized Control Trial 2025
- Regulated Cell Death in Endometriosis 2024
- Identification and Diagnostic Potential of Pyroptosis-Related Genes in Endometriosis: A Novel Bioinformatics Analysis 2024
- The NLRP3 activation-related signature predict the diagnosis and indicate immune characteristics in endometriosis 2023
- Molecular Mechanisms of Endometriosis Revealed Using Omics Data 2023
- Histone lactylation promotes cell proliferation, migration and invasion through targeting HMGB1 in endometriosis 2023
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-27T00:34:24.725753+00:00
License: CC0
· commercial use OK